6 Results for "

fsp1+inhibitor

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "fsp1+inhibitor" in MCE Product Catalog:

4
4 Cited Publications
Cat. No.: HY-163002
CAS No.: 951945-67-8
Target:  

Ferroptosis

Research Areas:  

Cancer

viFSP1 is a species-independent FSP1 inhibitor. viFSP1 directly inhibits FSP1 by targeting the highly conserved NAD(P)H binding pocket of FSP1. viFSP1 can induce Ferroptosis in FSP1-dependent cells. viFSP1 can be used in renal and breast cancer research [1] .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-153629
CAS No.: 862808-01-3
Purity:  99.56%
Target:  

Ferroptosis

Research Areas:  

Cancer

FSEN1 is a potent and non-competitive FSP1 inhibitor with an IC50 value of 313 nM. FSEN1 triggers iron death in cancer cells by inhibiting FSP1. FSEN1 can be used in research of cancer [1].
loading...
    loading...
Cat. No.: HY-157068
CAS No.: 1115910-36-5
Purity:  99.94%
Research Areas:  

Cancer

icFSP1 is a potent ferroptosis suppressor protein-1 (FSP1) inhibitor. icFSP1 triggers subcellular relocalization of FSP1 from the membrane and FSP1 condensation, in synergism with GPX4 inhibition. icFSP1 induces ferroptosis. icFSP1 shows antitumor activity against melanoma. [1].
loading...
    loading...
Cat. No.: HY-172896
Target:  

Ferroptosis

Research Areas:  

Cancer

FSP1-IN-1 (compound 39) is a potent FSP1 inhibitor with an IC50 of 35 nM. FSP1-IN-1 enhances RSL3 (HY-100218A)-induced lipid peroxide accumulation and sensitizes cancer cells to ferroptosis [1].
loading...
    loading...
Cat. No.: HY-175738
CAS No.: 3072951-35-7
Target:  

Ferroptosis

Research Areas:  

Cancer

afi-FSP1-1 is a Ferroptosis suppressor protein 1 (FSP1) inhibitor with an Ki of 0.283  μM. afi-FSP1-1 has a superior binding capacity to FSP1-FAD-NAD +. afi-FSP1-1 can induces ferroptosis in cancer cells. afi-FSP1-1 can be used for cancers research [1].
loading...
    loading...
Cat. No.: HY-184489
CAS No.: 328265-32-3
Research Areas:  

Cancer

PGP/FSP1-IN-1 is a dual PGP and FSP1 inhibitor and ferroptosis inducer that inhibits the oxidoreductase activity of FSP1. PGP/FSP1-IN-1 competes with NAD (P) H for binding to the pocket of FSP1 and induces FSP1 self-assembly, thereby directly blocking the catalytic function of the relevant enzyme. PGP/FSP1-IN-1 promotes lipid peroxidation and significantly enhances cellular sensitivity to ferroptosis when GPX4 activity is impaired or glutathione synthesis is inhibited. PGP/FSP1-IN-1 can be used in cancer research [1].
loading...
    loading...